The Joint Blog

DECEMBER 2, 2019

CBD could “significantly reduce opioid use and improve chronic pain and sleep quality among patients who are currently using opioids for pain management”, according to a new study. Data were collected at three different time points: baseline, 4, and 8 weeks.

Chronic Pain 68

Chronic Pain Sleep CBD Extraction 68

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

SpeedWeed

APRIL 10, 2021

Chronic pain patients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. An abstract of the research, “No pain, all gain? The data revealed a sustained improvement in the participants’ symptoms. More Research Needed For Chronic Pain.

Chronic Pain 52

Chronic Pain Patients Treatment Data 52

MedicalJane

JUNE 12, 2020

Primary conditions included neurological diseases such as MS and epilepsy, chronic pain from autoimmune diseases like fibromyalgia, back pain, cancer, insomnia, and psychiatric disorders such as anxiety, depression, and PTSD. Study Findings. Fifty-eight percent of patients used CBD-dominant products.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session.

Cannabinoids 213

Cannabinoids Sleep Clinical Trials CBD 213

Green Relief

MAY 7, 2021

BY NORML Analysis: Marijuana Use Data Fails to Support “Gateway Hypothesis” POSTED ON MAY 6, 2021 Boise, Idaho: Claims that the initiation of marijuana use is independently linked to the later use of other controlled substances are not supported by longitudinal data, according to a study published in the Journal of Experimental Criminology.

Data 98

Data Marijuana Chronic Pain Oil 98

Cannabis Law Report

AUGUST 10, 2021

Enters into the Chronic Pain Market with Psychedelics. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. 2 Pain 1994 Apr;57(1):5-15. billion in 2030.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Journaling can make cannabis use more mindful, deliberate and based on goals, past experiences, and your own personally cultivated data tracking what works best for you. But don’t stop there.

Wellness and Beauty 145

Wellness and Beauty Data Terpenes Patients 145

Project CBD

FEBRUARY 27, 2023

Across the eight studies they analyzed, the Australia-based authors identified increased levels of oleoylethanolamide and stearoylethanolamide (endocannabinoid-like molecules called N-Acylethanolamines that don’t bind with the cannabinoid receptors) in patients with these conditions compared to controls. Pain reports vol. 7,6 e1045.

THC 144

THC CBD Clinical Trials Sleep 144

TheAnswerPage

AUGUST 23, 2022

A June 2022 research study conducted in Ontario Canada (where cannabis-based medicine is legal at the federal level), assessed how chronic pain patients view the use of cannabis-based products for medicinal purposes. Do you think that most patients viewed cannabinoid-based therapeutics as an effective pain remedy?

Chronic Pain 75

Chronic Pain Medicine Collective Data 75

CannaMD

NOVEMBER 4, 2020

Cannabis has been used for centuries to manage chronic pain from all sources and, as a recent study highlights, its positive effects extend to migraines. The present study relied on Migraine Buddy , a leading mobile application that tracks migraine symptoms. The study surveyed 9,885 Migraine Buddy users in the U.S.

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

Healer

MARCH 26, 2021

That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 111

Consumption Patients Research and Development Data 111

The Cannigma

JULY 6, 2022

There have been some studies around cannabinoids and certain terpenes effects on sleep, but most of this research is preclinical, which means it’s not tested on humans yet. A chemotype is a grouping of cannabis varieties based on their chemical composition, organized by its most dominant cannabinoid. THC and sleep.

Sleep 117

Sleep Terpenes Strains Chronic Pain 117

PrestoDoctor

SEPTEMBER 6, 2023

Codeine works by binding to opioid receptors in the brain, blocking pain signals and providing a sense of relief. Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Furthermore, THC and CBD may have a synergistic effect.

Data 114

Data Chronic Pain Sleep Patients 114

StrainConnect

APRIL 23, 2019

Why Terpenes Are Vital To Your Cannabinoid Therapy. 3,4] By observing the terpene profile, cannabinoid presence and potency, and quantity of standard biomolecules like lipids and waxes, scientists can identify different chemovars. Terpenes also interact with the cannabinoids to help the therapeutic benefits take effect!

Terpenes 63

Terpenes Cannabinoids Therapy Sativa 63

Otherside Farms

JULY 4, 2022

The study of cannabinoids is fascinating because it sheds light on the body’s endocannabinoid system (ECS). What exactly are cannabinoids? CBC Wholesale and other cannabinoids also affect the ECS. A state of equilibrium gets maintained in your body through the activity of cannabinoids and their receptors.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

The Cannigma

FEBRUARY 11, 2021

Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

The Cannigma

MARCH 2, 2021

The research team compiled the study by extracting archival data from Reddit’s open source application programming interface between 2008-2018. The next closest was severe chronic pain at 33,401, followed by cancer at 5,205.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Veriheal

OCTOBER 19, 2020

Many people think that losing terpenes is a good trade for acquiring the cannabinoids but the terpene content responsible for the flavors and aromas associated with cannabis. The team of researchers at Eybna Technologies collected the data concerning the plant’s terpene profile through the use of their proprietary Headspace technology.

Terpenes 98

Terpenes Trichome Collective Extraction 98

Veriheal

OCTOBER 29, 2020

Science Magazine explains that the ‘harms’ refer to the adverse effects and negative impacts of cannabis consumption while the ‘endocannabinoid system’ refers to the body’s cannabinoid receptors and naturally produced endocannabinoids which the cannabis cannabinoids bind to. It also shows that three countries (the U.S,

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

The Cannigma

JULY 1, 2021

The data will also help doctors and researchers boost their knowledge, and assist in the creation of better alternative health products, according to People Science. The test will look at how the participants respond to the various products, and how changes in the cannabinoid makeup of those products affects sleep.

Sleep 101

Sleep Edibles Research and Development Data 101

Cannabis Law Report

JULY 13, 2021

Inhalation of cannabis extracts allows for a faster onset and higher bioavailability than tinctures and oils, and now that doctors can monitor a patient’s metered-dosage, more accurate patient data. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

Healer

APRIL 5, 2021

However, if you have not experienced the power of CBDA (and most people haven’t because CBDA is not included in most products that are manufactured with heat), this guide will explain what we are now learning about this powerful minor cannabinoid and how it can work together with CBD or in place of CBD to address and prevent symptoms.

CBD 98

CBD Chronic Pain Oil Topical 98

LifeCannMD

JANUARY 2, 2025

Clinical Applications Pain Management A systematic review by Whiting analyzed 79 trials and found moderate-quality evidence supporting the use of cannabinoids for chronic pain. A comprehensive review published in JAMA Oncology examined clinical data and case reports on cannabis as an anticancer agent.

Oil 98

Oil Concentrates Treatment Chronic Pain 98

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. Chronic pain.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

TheAnswerPage

DECEMBER 6, 2020

The findings of multiple randomized controlled trials (RCTs) indicate that cannabinoids effectively treat chronic pain. Do cannabinoids effectively treat the chronic pain associated with fibromyalgia? See Answer. See Answer.

Chronic Pain 40

Chronic Pain Cannabinoids Pharmaceutical Data 40

TheAnswerPage

JUNE 28, 2020

The findings of multiple RCTs indicate that cannabinoids effectively treat chronic pain. Do cannabinoids effectively treat the chronic pain associated with fibromyalgia? See Answer. See Answer.

Chronic Pain 40

Chronic Pain Cannabinoids Pharmaceutical Data 40

Sensi Seeds

DECEMBER 10, 2018

For the time being, and thanks to the onset of a new era of cannabis legalization, thousands of studies on cannabis and cannabinoids are published each year by the scientific community. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it.

Medicine 81

Medicine Research and Development Data Policy 81

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Journaling can make cannabis use more mindful, deliberate and based on goals, past experiences, and your own personally cultivated data tracking what works best for you. But don’t stop there.

Wellness and Beauty 72

Wellness and Beauty Data Terpenes Patients 72

Cannabis Law Report

NOVEMBER 2, 2021

NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Here’s the press release. So far this year, scientists have published over 3,600 papers.

Safety 52

Safety Patients Chronic Pain Advocacy 52

Green Relief

JANUARY 18, 2018

Due to its non-psychoactive healing properties, Cannabidiol (CBD) has become a very popular option for patients seeking a natural alternative to treat conditions such as chronic pain, anxiety, epilepsy, and more. UNDERSTANDING THE BENEFITS OF DIFFERENT CANNABINOIDS. 3%), resulting in very minimal psychoactive stimulation.

CBD 56

CBD Cannabinoids Chronic Pain Epilepsy 56

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40